Psychiatric medicine hasn’t seen much innovation in recent decades, even as many say that drugs like psilocybin, MDMA, and ...

The FDA rejected an application to approve MDMA, also known as ecstasy, as a treatment for PTSD. Next up among the ...

Reuters.com is your online source for the latest news stories and current events, ensuring our readers up to date with any ...

Advocates are pushing for approval of psychedelic-assisted therapy from the FDA, seeking a means of therapy without fear of ...

The results of a new study suggests that more than 5 million Americans undergoing treatment for depression could benefit from ...

comments on the U.S. Food and Drug Administration's ("FDA") decision to not approve Lykos Therapeutics' new drug application for MDMA (midomafetamine capsules) used in combination with psychological ...

While Lykos Therapeutics’ MDMA therapy was rejected by the FDA, psychedelic therapy advocates remain optimistic about the ...

A Boulder-based therapist characterized the decision as an enormous setback for those seeking treatment for PTSD.

Esketamine (Spravato) was the first new depression treatment in decades. It brought depressed people hope. It also brought ...

More than 5 million Americans in treatment for depression could benefit from therapy with psilocybin -- the active ingredient ...

As Psychiatric Times reported, this decision puts on hold what could have been a landmark approval for the treatment of PTSD with MDMA, also known as midomafetamine. Despite the setback, Lykos ...

Efforts to make MDMA legally available as a psychotherapeutic catalyst hit a daunting roadblock in August. The Food and Drug ...